Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-20

Clinical Trial Update: Head Mounted Eye Tracking Aide for Loss of Central Vision (HETALCEV) [NA]

View source ↗

Summary

The clinical trial NCT02829606 evaluating a head-mounted eye tracking device for loss of central vision in age-related macular degeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Head Mounted Eye Tracking Aide (HETALCEV)

Snippet

Sponsor: University of Minnesota | Conditions: Age-related Macular Degeneration | NA | Status: COMPLETED